Horizon Therapeutics Earnings Preview

On Monday, February 01, Horizon Therapeutics HZNP will release its latest earnings report. Benzinga's outlook for Horizon Therapeutics is included in the following report.

What Are Earnings, Net Income, And Earnings Per Share?

Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS.

Earnings And Revenue

Horizon Therapeutics earnings will be near $1.03 per share on sales of $682.68 million, according to analysts. Horizon Therapeutics EPS in the same period a year ago totaled $0.56. Revenue was $363.55 million.

Why Analyst Estimates And Earnings Surprises Are Important

Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.

If the company were to report earnings in line when it publishes results Monday, quarterly profit would be up 83.93%. Sales would be up 87.78% from the year-ago period. In comparison to analyst estimates in the past, here is how the company's reported EPS stacks up:

Stock Performance

Over the last 52-week period, shares are up 113.7%. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.

Do not be surprised to see the stock move on comments made during its conference call. Horizon Therapeutics is scheduled to hold the call at 08:00:00 ET and can be accessed here.